Ipratropium Bromide NDC 0487-9801

NDC codes

FDA NDC Directory

Product NDC (as listed)0487-9801Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00487-9801Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0487-9801-01	00487980101	30 POUCH in 1 CARTON (0487-9801-01) / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSEMarketed from Sep 27, 2001
0487-9801-02	00487980102	30 BAG in 1 BOX (0487-9801-02) / 1 POUCH in 1 BAG / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSEMarketed from Sep 27, 2001
0487-9801-25	00487980125	1 POUCH in 1 CARTON (0487-9801-25) / 25 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSEMarketed from Sep 27, 2001
0487-9801-30	00487980130	1 POUCH in 1 CARTON (0487-9801-30) / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSEMarketed from Sep 27, 2001
0487-9801-60	00487980160	2 POUCH in 1 CARTON (0487-9801-60) / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSEMarketed from Sep 27, 2001

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ipratropium Bromide
Generic name (nonproprietary): ipratropium bromide
Active ingredients: Ipratropium bromide — .5 mg/2.5mL
Dosage form: Solution
Route: Respiratory (Inhalation)
Labeler: Nephron Pharmaceuticals Corporation
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075562
Marketing start: Sep 27, 2001
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 0487-9801_3249e47e-0ac1-e2a5-e063-6394a90a9993SPL ID 3249e47e-0ac1-e2a5-e063-6394a90a9993SPL set ID db8095db-d1fd-4099-9fb1-d1ad4e284976RxCUI 836358UNII J697UZ2A9JUPC 0304879801011, 0304879801004
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400487980101 followed by a unit qualifier and the quantity

Package 00487-9801-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 8, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ipratropium bromide inhalation solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075562

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075562
Product	Strength	Form · route	Labeler	Product NDC
Ipratropium Bromide	Ipratropium bromide .5 mg/2.5mL	SolutionRespiratory (Inhalation)	Rising Pharma Holdings, Inc.	64980-640
Ipratropium Bromide	Ipratropium bromide .5 mg/2.5mL	SolutionRespiratory (Inhalation)	Chartwell RX, LLC	62135-830